Skip to main content
. Author manuscript; available in PMC: 2014 Sep 30.
Published in final edited form as: Pediatr Diabetes. 2011 Dec 13;13(5):408–418. doi: 10.1111/j.1399-5448.2011.00836.x

Table 3.

Effects of individual contributing factors and multiple logistic regression models for risk factors associated with C-peptide levels at 1-month (A), and the end of partial remission at 9-month (B) post T1D diagnosis.

A. Stimulated C-peptides at 1-month post diagnosis
R2 t-ratio P
Individual parameters
C4A CNV 0.215 2.87 0.0075
 C4A cone. 0.209 2.82 0.0085
HLA-DR3 * 0.138 −2.20 0.036
 BMI 0.310 3.67 0.0009
 Z-BMI 0.184 2.61 0.014
 age of onset 0.06 1.43 0.162
Regression Model 1: C4A CNV and BMI
 model 0.405 9.85* 0.0005
C4A CNV 2.15 0.040
 BMI 3.04 0.005
Regression Model 2: C4A protein cone, and BMI
 model 0.423 10.6 0.0003
 C4A cone. 2.39 0.024
 BMI 3.28 0.0027
Regression Model 3: HLA-DR3 and BMI
 model 0.405 9.87 0.0005
HLA-DR3 −2.16 0.040
 BMI 3.61 0.0012
B. End of partial disease remission at 9-month
R2 χ 2 P
Individual parameters
C4B CNV 0.162 5.74 0.0166
 C4B cone. 0.355 12.6 0.0004
DR3/DR4 * 0.161 5.71 0.0169
Regression Model 4: C4B-CNV and DR3/DR4
 model 0.355 12.6 0.0018
C4B-CHV 6.88 0.0087
DR3/DR4 * 6.85 0.0089
Regression Model 4: C4B cone. andDR3/DR4
 model 0.471 16.8 0.0002
 C4B cone. 11.0 0.0009
DR3/DR4 * 4.09 0.043
*

inverse association

F-ratio value is presented.